D F Vollherbst1, C M Sommer2,3, C Ulfert1, J Pfaff1, M Bendszus1, M A Möhlenbruch4. 1. From the Department of Neuroradiology (D.F.V., C.U., J.P., M.B., M.A.M.). 2. Clinic for Diagnostic and Interventional Radiology (C.M.S.), University Hospital Heidelberg, Heidelberg, Germany. 3. Clinic for Diagnostic and Interventional Radiology (C.M.S.), Klinikum Stuttgart, Stuttgart, Germany. 4. From the Department of Neuroradiology (D.F.V., C.U., J.P., M.B., M.A.M.) markus.moehlenbruch@med.uni-heidelberg.de.
Abstract
BACKGROUND AND PURPOSE: Embolization plays a key role in the treatment of arteriovenous malformations. The aim of this study was to evaluate an established (Onyx) and a novel (precipitating hydrophobic injectable liquid [PHIL]) liquid embolic agent in an in vitro AVM model. MATERIALS AND METHODS: An AVM model was integrated into a circuit system. The artificial nidus (subdivided into 28 honeycomb-like sections) was embolized with Onyx 18 (group Onyx; n = 8) or PHIL 25 (group PHIL; n = 8) with different pause times between the injections (30 and 60 seconds, n = 4 per study group) by using a 1.3F microcatheter. Procedure times, number of injections, embolization success (defined as the number of filled sections of the artificial nidus), volume of embolic agent, and frequency and extent of reflux and draining vein embolization were assessed. RESULTS: Embolization success was comparable between Onyx and PHIL. Shorter pause times resulted in a significantly higher embolization success for PHIL (median embolization score, 28 versus 18; P = .011). Compared with Onyx, lower volumes of PHIL were required for the same extent of embolization (median volume per section of the artificial nidus, 15.5 versus 3.6 μL; P < .001). CONCLUSIONS: While the embolization success was comparable for Onyx and PHIL, pause time had a considerable effect on the embolization success in an in vitro AVM model. Compared with Onyx, lower volumes of PHIL were required for the same extent of embolization.
BACKGROUND AND PURPOSE: Embolization plays a key role in the treatment of arteriovenous malformations. The aim of this study was to evaluate an established (Onyx) and a novel (precipitating hydrophobic injectable liquid [PHIL]) liquid embolic agent in an in vitro AVM model. MATERIALS AND METHODS: An AVM model was integrated into a circuit system. The artificial nidus (subdivided into 28 honeycomb-like sections) was embolized with Onyx 18 (group Onyx; n = 8) or PHIL 25 (group PHIL; n = 8) with different pause times between the injections (30 and 60 seconds, n = 4 per study group) by using a 1.3F microcatheter. Procedure times, number of injections, embolization success (defined as the number of filled sections of the artificial nidus), volume of embolic agent, and frequency and extent of reflux and draining vein embolization were assessed. RESULTS: Embolization success was comparable between Onyx and PHIL. Shorter pause times resulted in a significantly higher embolization success for PHIL (median embolization score, 28 versus 18; P = .011). Compared with Onyx, lower volumes of PHIL were required for the same extent of embolization (median volume per section of the artificial nidus, 15.5 versus 3.6 μL; P < .001). CONCLUSIONS: While the embolization success was comparable for Onyx and PHIL, pause time had a considerable effect on the embolization success in an in vitro AVM model. Compared with Onyx, lower volumes of PHIL were required for the same extent of embolization.
Authors: L Pierot; C Cognard; D Herbreteau; H Fransen; W J van Rooij; E Boccardi; A Beltramello; N Sourour; K Kupcs; A Biondi; A Bonafé; W Reith; A Casasco Journal: Eur Radiol Date: 2013-05-08 Impact factor: 5.315
Authors: Edgar A Samaniego; Vladimir Kalousek; German Abdo; Santiago Ortega-Gutierrez Journal: J Neurointerv Surg Date: 2016-01-27 Impact factor: 5.836
Authors: Edgar A Samaniego; Colin P Derdeyn; Minako Hayakawa; David Hasan; Santiago Ortega-Gutierrez Journal: Interv Neuroradiol Date: 2018-07-04 Impact factor: 1.610
Authors: Dominik F Vollherbst; Ruth Otto; Thuy Do; Hans U Kauczor; Martin Bendszus; Christof M Sommer; Markus A Möhlenbruch Journal: Interv Neuroradiol Date: 2018-07-04 Impact factor: 1.610
Authors: N Schmitt; R O Floca; D Paech; R A El Shafie; F Seker; M Bendszus; M A Möhlenbruch; D F Vollherbst Journal: AJNR Am J Neuroradiol Date: 2020-11-19 Impact factor: 3.825
Authors: Boris Rivkin; Christian Becker; Balram Singh; Azaam Aziz; Farzin Akbar; Aleksandr Egunov; Dmitriy D Karnaushenko; Ronald Naumann; Rudolf Schäfer; Mariana Medina-Sánchez; Daniil Karnaushenko; Oliver G Schmidt Journal: Sci Adv Date: 2021-12-17 Impact factor: 14.136